Mobic and Pregnancy
Most healthcare providers do not recommend taking Mobic during pregnancy; and taking it at all during the third trimester should be avoided. Despite these warnings, however, a healthcare provider may still prescribe Mobic early in a woman's pregnancy if he or she believes that the benefits outweigh the possible risks to the unborn child.
Most healthcare providers do not recommend taking Mobic® (meloxicam) during pregnancy because it can possibly cause problems to the unborn child or complicate labor and delivery. Taking Mobic at all during the third trimester should be avoided. Early in the pregnancy, however, it is possible that your healthcare provider may recommend taking Mobic. This is because he or she feels that the benefits to you outweigh the possible risks to your unborn child.
Mobic is considered a pregnancy Category C medicine by the U.S. Food and Drug Administration (FDA). The FDA uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been tested in pregnant humans but show side effects to the fetus during animal studies. However, it is important to note that animals do not always respond to medicines the same way that humans do. A pregnancy Category C medicine may still be given to a pregnant woman if her healthcare provider believes that its benefits outweigh the possible risks to her unborn child.
If you are pregnant or thinking of becoming pregnant while taking Mobic, let your healthcare provider know. He or she will consider both the benefits and risks of pregnancy and Mobic before making a recommendation for your particular situation.